|
2013
|
Invention
|
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof. Th... |
|
2011
|
Invention
|
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof. The present i... |
|
|
Invention
|
Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses the... |
|
2010
|
Invention
|
Heterocyclic compounds, methods for the preparation thereof, and uses thereof. The compounds of t... |
|
|
Invention
|
Compounds having 5-ht6 receptor affinity.
The present disclosure provides compounds having affin... |
|
|
Invention
|
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyrid... |
|
2009
|
Invention
|
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof. T... |
|
|
Invention
|
4'-amino cyclic compounds having 5-ht6 receptor affinity. The present disclosure provides compoun... |
|
|
Invention
|
Condensed heterocyclic compounds having 5-ht6 receptor affinity. The present disclosure provides ... |
|
|
Invention
|
Pyrrolo [3, 2-b]pyridines and pyrazolo [4, 3 -b] pyridines having 5-ht6 receptor affinity. The pr... |
|
|
Invention
|
4'-amino cyclic compounds having 5-ht6 receptor affinity.
The present disclosure provides compou... |
|
|
Invention
|
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity.
The present disclosure provides c... |
|
|
Invention
|
Acyclic compounds having 5-ht6 receptor affinity.
The present disclosure provides compounds havi... |
|
|
Invention
|
Phosphodiesterase 4 inhibitors.
PDE4 inhibition is achieved by novel compounds, e.g., N-substitu... |
|
|
Invention
|
Phosphodiesterase 4 inhibitors. PDE4 inhibition is achieved by novel compounds, e.g., N-substitut... |
|
|
Invention
|
Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors.
Certain thienopyrimidin... |
|
|
Invention
|
Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity. The present disclosur... |
|
|
Invention
|
Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity.
The present disclosu... |
|
|
Invention
|
Pyrrolo-pyridine-3-yl-piperazine derivatives having 5-ht6 receptor affinity. The present disclosu... |
|
2008
|
Invention
|
Combinations of pde4 inhibitors and antipsychotics for the treatment of psychotic disorders. The ... |
|
|
Invention
|
Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereo... |
|
|
Invention
|
Methods of treatment using (+)- isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro... |
|
|
Invention
|
(1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholin... |
|
|
Invention
|
Methods of treating alzheimer's disease with (+) - isopropyl 2-methoxyethyl 4-(2-chloro-3- cyano-... |
|
|
Invention
|
Isoquinolone derivatives as phosphodiesterase 10 inhibitors. The present invention is directed to... |
|
|
Invention
|
Isoquinolone derivatives as phosphodiesterase 10 inhibitors.
The present invention is directed t... |
|
|
Invention
|
3' substituted compounds having 5-ht6 receptor affinity.
The present disclosure provides compoun... |
|
|
Invention
|
3' substituted compounds having 5-ht6 receptor affinity. The present disclosure provides compound... |
|
|
Invention
|
4' substituted compounds having 5-ht6 receptor affinity.
The present disclosure provides compoun... |
|
|
Invention
|
4' substituted compounds having 5-ht6 receptor affinity. The present disclosure provides compound... |
|
|
Invention
|
Phosphodiesterase 4 inhibitors. Selective PDE4 inhibition is achieved by aryl and heteroaryl pyra... |
|
|
Invention
|
Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith.... |
|
|
Invention
|
Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith ... |
|
|
Invention
|
6' substituted compounds having 5-ht6 receptor affinity. The present disclosure provides compound... |
|
|
Invention
|
6' substituted compounds having 5-ht6 receptor affinity.
The present disclosure provides compoun... |
|
|
Invention
|
6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity. The present discl... |
|
2007
|
Invention
|
Pharmaceutical formulations for 1,4-dihyrdropyridine compounds having improved solubility. A phar... |
|
|
Invention
|
Phosphodiesterase 10 inhibitors.
The present invention if directed to certain cinnoline compound... |
|
|
Invention
|
Compounds having 5-ht6 receptor affinity. The present disclosure provides compounds having affini... |
|
2004
|
Invention
|
Methods of treatment using (+)-isopropyl 2-ethoxyethyl-4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,... |
